{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T06:40:18Z","timestamp":1771051218826,"version":"3.50.1"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007670","name":"Dalhousie Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007670","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005785","name":"Dalhousie University Faculty of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005785","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002977","name":"Dalhousie University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002977","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000194","name":"Nova Scotia Health Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000194","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.neurobiolaging.2021.02.025","type":"journal-article","created":{"date-parts":[[2021,3,5]],"date-time":"2021-03-05T16:25:16Z","timestamp":1614961516000},"page":"31-41","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Clinicopathological correlations and cholinesterase expression in early-onset familial Alzheimer's disease with the presenilin 1 mutation, Leu235Pro"],"prefix":"10.1016","volume":"103","author":[{"given":"Meghan K.","family":"Cash","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth","family":"Rockwood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3512-8015","authenticated-orcid":false,"given":"John D.","family":"Fisk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9881-7761","authenticated-orcid":false,"given":"Sultan","family":"Darvesh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.neurobiolaging.2021.02.025_bib0001","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.neulet.2011.03.084","article-title":"A novel PSEN1 gene mutation (L235R) associated with familial early-onset Alzheimer's disease","volume":"496","author":"Antonell","year":"2011","journal-title":"Neurosci Lett"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2021.02.025_bib0002","doi-asserted-by":"crossref","first-page":"15","DOI":"10.5114\/fn.2015.49970","article-title":"Laminar distribution of \u03b2-amyloid (A\u03b2) peptide deposits in the frontal lobe in familial and sporadic Alzheimer's disease","volume":"53","author":"Armstrong","year":"2015","journal-title":"Folia Neuropathol"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2021.02.025_bib0003","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1471-4159.1986.tb02858.x","article-title":"Molecular forms of acetylcholinesterase and butyrylcholinesterase in the aged human central nervous system","volume":"47","author":"Atack","year":"1986","journal-title":"J Neurochem"},{"issue":"6","key":"10.1016\/j.neurobiolaging.2021.02.025_bib0004","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1111\/j.1471-4159.1987.tb05724.x","article-title":"Molecular forms of butyrylcholinesterase in the human neocortex during development and degeneration of the cortical cholinergic system","volume":"48","author":"Atack","year":"1987","journal-title":"J Neurochem"},{"issue":"4558","key":"10.1016\/j.neurobiolaging.2021.02.025_bib0005","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1126\/science.7046051","article-title":"The cholinergic hypothesis of geriatric memory dysfunction","volume":"217","author":"Bartus","year":"1982","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.neurobiolaging.2021.02.025_bib0006","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1007\/BF00296792","article-title":"Senile plaques, amyloid \u03b2-protein, and acetylcholinesterase fibres: laminar distributions in Alzheimer's disease striate cortex","volume":"83","author":"Beach","year":"1992","journal-title":"Acta Neuropathol"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2021.02.025_bib0007","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/ana.25380","article-title":"Attributable risk of Alzheimer's dementia attributed to age-related neuropathologies","volume":"85","author":"Boyle","year":"2019","journal-title":"Ann Neurol"},{"issue":"4","key":"10.1016\/j.neurobiolaging.2021.02.025_bib0008","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1111\/j.1471-4159.1988.tb03091.x","article-title":"Butyrylcholinesterase in human brain and acetylcholinesterase in human plasma: trace enzymes measured by two-site immunoassay","volume":"51","author":"Brimijoin","year":"1988","journal-title":"J Neurochem"},{"issue":"10","key":"10.1016\/j.neurobiolaging.2021.02.025_bib0009","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1097\/00001756-199607080-00009","article-title":"A novel presenilin 1 mutation resulting in familial Alzheimer's disease with an onset age of 29 years","volume":"7","author":"Campion","year":"1996","journal-title":"NeuroReport"},{"issue":"3","key":"10.1016\/j.neurobiolaging.2021.02.025_bib0010","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1086\/302553","article-title":"Early-onset autosomal dominant Alzheimer disease: prevalence, genetic heterogeneity, and mutation spectrum","volume":"65","author":"Campion","year":"1999","journal-title":"Am J Hum Genet"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2021.02.025_bib0011","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1046\/j.1471-4159.2003.01985.x","article-title":"Acetylcholinesterase induces neuronal cell loss, astrocyte hypertrophy and behavioral deficits in mammalian hippocampus","volume":"87","author":"Chac\u00f3n","year":"2003","journal-title":"J Neurochem"},{"issue":"7","key":"10.1016\/j.neurobiolaging.2021.02.025_bib0012","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1001\/jamaneurol.2015.0606","article-title":"Clinical features of Alzheimer disease with and without Lewy bodies","volume":"72","author":"Chung","year":"2015","journal-title":"JAMA Neurol"},{"issue":"4589","key":"10.1016\/j.neurobiolaging.2021.02.025_bib0013","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1126\/science.6338589","article-title":"Alzheimer's disease: a disorder of cortical cholinergic innervation","volume":"219","author":"Coyle","year":"1983","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.neurobiolaging.2021.02.025_bib0014","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1002\/humu.22117","article-title":"Locus-specific mutation databases for neurodegenerative brain diseases","volume":"33","author":"Cruts","year":"2012","journal-title":"Hum Mutat"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2021.02.025_bib0015","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/NEN.0b013e31823cc7a6","article-title":"Butyrylcholinesterase is associated with beta-amyloid plaques in the transgenic APPSWE\/PSEN1dE9 mouse model of Alzheimer disease","volume":"71","author":"Darvesh","year":"2012","journal-title":"J Neuropathol Exp Neurol"},{"issue":"3","key":"10.1016\/j.neurobiolaging.2021.02.025_bib0016","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1002\/(SICI)1096-9861(19980413)393:3<374::AID-CNE8>3.0.CO;2-Z","article-title":"Distribution of butyrylcholinesterase in the human amygdala and hippocampal formation","volume":"393","author":"Darvesh","year":"1998","journal-title":"J Comp Neurol"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2021.02.025_bib0017","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/cne.10751","article-title":"Differential distribution of butyrylcholinesterase and acetylcholinesterase in the human thalamus","volume":"463","author":"Darvesh","year":"2003","journal-title":"J Comp Neurol"},{"issue":"2","key":"10.1016\/j.neurobiolaging.2021.02.025_bib0018","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nrn1035","article-title":"Neurobiology of butyrylcholinesterase","volume":"4","author":"Darvesh","year":"2003","journal-title":"Nat Rev Neurosci"},{"issue":"Pt B","key":"10.1016\/j.neurobiolaging.2021.02.025_bib0019","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.cbi.2016.04.022","article-title":"Reduced fibrillar \u03b2-amyloid in subcortical structures in a butyrylcholinesterase-knockout Alzheimer disease mouse model","volume":"259","author":"Darvesh","year":"2016","journal-title":"Chem Biol Interact"},{"issue":"5","key":"10.1016\/j.neurobiolaging.2021.02.025_bib0020","doi-asserted-by":"crossref","first-page":"386","DOI":"10.2174\/156720510791383868","article-title":"Biochemical and histochemical comparison of cholinesterases in normal and Alzheimer brain tissues","volume":"7","author":"Darvesh","year":"2010","journal-title":"Curr Alzheimer Res"},{"issue":"35","key":"10.1016\/j.neurobiolaging.2021.02.025_bib0021","doi-asserted-by":"crossref","first-page":"10447","DOI":"10.1021\/bi0101392","article-title":"A structural motif of acetylcholinesterase that promotes amyloid \u03b2-peptide fibril formation","volume":"40","author":"De Ferrari","year":"2001","journal-title":"Biochemistry"},{"key":"10.1016\/j.neurobiolaging.2021.02.025_bib0022","series-title":"Diagnosis and Management in Dementia: The Neuroscience of Dementia","first-page":"263","article-title":"Butyrylcholinesterase as a biomarker in Alzheimer's disease","author":"DeBay","year":"2020"},{"issue":"23","key":"10.1016\/j.neurobiolaging.2021.02.025_bib0023","doi-asserted-by":"crossref","first-page":"8628","DOI":"10.1073\/pnas.0602922103","article-title":"Butyrylcholinesterase attenuates amyloid fibril formation in vitro","volume":"103","author":"Diamant","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2021.02.025_bib0024","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1750-1326-5-4","article-title":"Amyloid-\u03b2-Acetylcholinesterase complexes potentiate neurodegenerative changes induced by the A\u03b2 peptide. Implications for the pathogenesis of Alzheimer's disease","volume":"5","author":"Dinamarca","year":"2010","journal-title":"Mol Neurodegener"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2021.02.025_bib0025","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1152\/jn.00626.2002","article-title":"An unfolded map of the cerebellar dentate nucleus and its projections to the cerebral cortex","volume":"89","author":"Dum","year":"2003","journal-title":"J Neurophysiol"},{"issue":"2","key":"10.1016\/j.neurobiolaging.2021.02.025_bib0026","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s10048-005-0211-x","article-title":"Novel mutations and repeated findings of mutations in familial Alzheimer disease","volume":"6","author":"Finckh","year":"2005","journal-title":"Neurogenetics"},{"issue":"3","key":"10.1016\/j.neurobiolaging.2021.02.025_bib0027","doi-asserted-by":"crossref","first-page":"401","DOI":"10.4103\/1673-5374.266046","article-title":"Can mouse models mimic sporadic Alzheimer's disease?","volume":"15","author":"Foidl","year":"2020","journal-title":"Neural Regen Res"},{"issue":"3","key":"10.1016\/j.neurobiolaging.2021.02.025_bib0028","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\"Mini-mental state\". A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J Psychiatr Res"},{"issue":"Suppl 2","key":"10.1016\/j.neurobiolaging.2021.02.025_bib0029","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/00002093-199501002-00005","article-title":"Cholinesterases and the pathology of Alzheimer disease","volume":"9","author":"Geula","year":"1995","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.1016\/j.neurobiolaging.2021.02.025_bib0030","series-title":"Butyrylcholinesterase: its function and inhibitors","author":"Giacobini","year":"2003"},{"issue":"6","key":"10.1016\/j.neurobiolaging.2021.02.025_bib0031","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1002\/ana.410420613","article-title":"Butyrylcholinesterase in the life cycle of amyloid plaques","volume":"42","author":"Guillozet","year":"1997","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurobiolaging.2021.02.025_bib0032","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopsych.2020.01.016","article-title":"Disentangling heterogeneity in Alzheimer's disease and related dementias using data-driven methods","author":"Habes","year":"2020","journal-title":"Biol Psychiatry"},{"issue":"3","key":"10.1016\/j.neurobiolaging.2021.02.025_bib0033","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1750-3639.2000.tb00269.x","article-title":"Lewy bodies in Alzheimer's disease: a neuropathological review of 145 cases using alpha-synuclein immunohistochemistry","volume":"10","author":"Hamilton","year":"2000","journal-title":"Brain Pathol"},{"issue":"7","key":"10.1016\/j.neurobiolaging.2021.02.025_bib0034","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/nan.12423","article-title":"Cholinesterases in normal and Alzheimer's disease primary olfactory gyrus","volume":"43","author":"Hamodat","year":"2017","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"77","key":"10.1016\/j.neurobiolaging.2021.02.025_bib0035","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3002369","article-title":"Alzheimer's disease: the challenge of the second century","volume":"3","author":"Holtzman","year":"2011","journal-title":"Sci Transl Med"},{"issue":"4","key":"10.1016\/j.neurobiolaging.2021.02.025_bib0036","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S0896-6273(00)80108-7","article-title":"Acetylcholinesterase accelerates assembly of amyloid-\u03b2-peptides into Alzheimer's fibrils: possible role of the peripheral site of the enzyme","volume":"16","author":"Inestrosa","year":"1996","journal-title":"Neuron"},{"issue":"5S","key":"10.1016\/j.neurobiolaging.2021.02.025_bib0037","doi-asserted-by":"crossref","first-page":"S72","DOI":"10.1016\/j.jalz.2012.10.007","article-title":"Florbetapir (F18-AV-45) PET to assess amyloid burden in Alzheimer's disease dementia, mild cognitive impairment, and normal aging","volume":"9","author":"Johnson","year":"2013","journal-title":"Alzheimers Dement"},{"issue":"3","key":"10.1016\/j.neurobiolaging.2021.02.025_bib0038","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1001\/archneur.63.3.370","article-title":"Lewy body pathology in familial Alzheimer disease: evidence for disease- and mutation-specific pathologic phenotype","volume":"63","author":"Leverenz","year":"2006","journal-title":"Arch Neurol"},{"issue":"5","key":"10.1016\/j.neurobiolaging.2021.02.025_bib0039","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/S0002-9440(10)65722-7","article-title":"Lewy bodies contain altered \u03b1-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes","volume":"153","author":"Lippa","year":"1998","journal-title":"Am J Pathol"},{"key":"10.1016\/j.neurobiolaging.2021.02.025_bib0040","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1750-1326-3-20","article-title":"Histopathological and molecular heterogeneity among individuals with dementia associated with Presenilin mutations","volume":"3","author":"Maarouf","year":"2008","journal-title":"Mol Neurodegener"},{"issue":"2","key":"10.1016\/j.neurobiolaging.2021.02.025_bib0041","doi-asserted-by":"crossref","first-page":"491","DOI":"10.3233\/JAD-170164","article-title":"Quantification of butyrylcholinesterase activity as a sensitive and specific biomarker of Alzheimer's disease","volume":"58","author":"Macdonald","year":"2017","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.neurobiolaging.2021.02.025_bib0042","first-page":"174","article-title":"Cerebellar pathology in Alzheimer's disease","volume":"22","author":"Mavroudis","year":"2019","journal-title":"Hell J Nucl Med"},{"issue":"3","key":"10.1016\/j.neurobiolaging.2021.02.025_bib0043","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimers Dement"},{"issue":"5","key":"10.1016\/j.neurobiolaging.2021.02.025_bib0044","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1002\/ana.410360506","article-title":"Butyrylcholinesterase reactivity differentiates the amyloid plaques of aging from those of dementia","volume":"36","author":"Mesulam","year":"1994","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2021.02.025_bib0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00401-011-0910-3","article-title":"National Institute on Aging\u2013Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach","volume":"123","author":"Montine","year":"2012","journal-title":"Acta Neuropathol"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2021.02.025_bib0046","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0165-0270(92)90066-M","article-title":"Cholinesterase histochemistry in the human brain: effect of various fixation and storage conditions","volume":"43","author":"Mor\u00e1n","year":"1992","journal-title":"J Neurosci Methods"},{"issue":"4","key":"10.1016\/j.neurobiolaging.2021.02.025_bib0047","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1365-2990.1978.tb00545.x","article-title":"Changes in brain cholinesterases in senile dementia of Alzheimer type","volume":"4","author":"Perry","year":"1978","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"3","key":"10.1016\/j.neurobiolaging.2021.02.025_bib0048","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/mp.2013.19","article-title":"APOE and BCHE as modulators of cerebral amyloid deposition: a florbetapir PET genome-wide association study","volume":"19","author":"Ramanan","year":"2014","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2021.02.025_bib0049","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.neuroscience.2015.04.039","article-title":"Butyrylcholinesterase-knockout reduces brain deposition of fibrillar beta-amyloid in an Alzheimer mouse model","volume":"298","author":"Reid","year":"2015","journal-title":"Neuroscience"},{"issue":"4","key":"10.1016\/j.neurobiolaging.2021.02.025_bib0050","first-page":"629","article-title":"Brief Cognitive Rating Scale (BCRS)","volume":"24","author":"Reisberg","year":"1988","journal-title":"Psychopharmacol Bull"},{"issue":"6","key":"10.1016\/j.neurobiolaging.2021.02.025_bib0051","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1016\/S0002-9440(10)63774-1","article-title":"Acetylcholinesterase-A\u03b2 complexes are more toxic than A\u03b2 fibrils in rat hippocampus: effect on rat \u03b2-amyloid aggregation, laminin expression, reactive astrocytosis, and neuronal cell loss","volume":"164","author":"Reyes","year":"2004","journal-title":"Am J Pathol"},{"issue":"4","key":"10.1016\/j.neurobiolaging.2021.02.025_bib0052","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1212\/WNL.57.4.621","article-title":"Screening for PS1 mutations in a referral-based series of AD cases: 21 novel mutations","volume":"57","author":"Rogaeva","year":"2001","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2021.02.025_bib0053","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/ane.13028","article-title":"Lewy body pathology in Alzheimer's disease: a clinicopathological prospective study","volume":"139","author":"Savica","year":"2019","journal-title":"Acta Neurol Scand"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2021.02.025_bib0054","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s00401-009-0521-4","article-title":"Variations in the neuropathology of familial Alzheimer's disease","volume":"118","author":"Shepherd","year":"2009","journal-title":"Acta Neuropathol"},{"issue":"7","key":"10.1016\/j.neurobiolaging.2021.02.025_bib0055","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1097\/01.jnen.0000225908.90052.07","article-title":"Alzheimer disease with amygdala Lewy bodies: a distinct form of alpha-synucleinopathy","volume":"65","author":"Uchikado","year":"2006","journal-title":"J Neuropathol Exp Neurol"},{"issue":"2","key":"10.1016\/j.neurobiolaging.2021.02.025_bib0056","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S1474-4422(18)30371-5","article-title":"Investigation of frailty as a moderator of the relationship between neuropathology and dementia in Alzheimer's disease: a cross-sectional analysis of data from the rush memory and aging project","volume":"18","author":"Wallace","year":"2019","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neurobiolaging.2021.02.025_bib0057","doi-asserted-by":"crossref","DOI":"10.1002\/ana.25711","article-title":"Normative cognitive decline in old age","author":"Wilson","year":"2020","journal-title":"Ann Neurol"},{"issue":"3","key":"10.1016\/j.neurobiolaging.2021.02.025_bib0058","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/ana.410340312","article-title":"Neurological cholinesterases in the normal brain and in Alzheimer's disease: relationship to plaques, tangles, and patterns of selective vulnerability","volume":"34","author":"Wright","year":"1993","journal-title":"Ann Neurol"},{"issue":"4","key":"10.1016\/j.neurobiolaging.2021.02.025_bib0059","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1017\/S0317167100013949","article-title":"Early-onset familial Alzheimer's disease (EOFAD)","volume":"39","author":"Wu","year":"2012","journal-title":"Can J Neurol Sci"}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458021000828?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458021000828?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T11:36:39Z","timestamp":1759318599000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458021000828"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":59,"alternative-id":["S0197458021000828"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2021.02.025","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinicopathological correlations and cholinesterase expression in early-onset familial Alzheimer's disease with the presenilin 1 mutation, Leu235Pro","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2021.02.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}